InsiderClue
Insiders · Profile

Mahatme Sandesh

EVP, CFO & CBO at Sarepta Therapeutics. Filing since 20 Aug 2013. CIK 0001511034

Company
Date
Role
Action
Shares
Amount
Of holding
SRPT Sarepta Therapeutics, Inc.
13 Dec 2019
EVP, CFO & CBO
Sold, plan not stated
125,000
$15.69M
80.6%
SRPT Sarepta Therapeutics, Inc.
7 Feb 2019
EVP, CFO & CBO
Sold, plan not stated
65,000
$9.43M
88.3%
SRPT Sarepta Therapeutics, Inc.
31 Jan 2019
EVP, CFO & CBO
Sold, plan not stated
21,198
$2.77M
71.0%
SRPT Sarepta Therapeutics, Inc.
30 Jan 2019
EVP, CFO & CBO
Sold, plan not stated
43,802
$5.69M
83.5%
SRPT Sarepta Therapeutics, Inc.
24 Oct 2018
EVP, CFO & CBO
Sold, plan not stated
107,524
$13.74M
83.9%
SRPT Sarepta Therapeutics, Inc.
20 Jul 2017
EVP, CFO & CBO
Sold, plan not stated
50,000
$2.05M
60.7%
SRPT Sarepta Therapeutics, Inc.
17 Oct 2016
Senior Vice President, CFO
Sold, plan not stated
30,000
$1.50M
48.8%
SRPT Sarepta Therapeutics, Inc.
20 Aug 2013
Senior Vice President, CFO
Bought
5,000
$155.50K
opened
8 decisions on file.